Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Oct 27, 2026; 18(10): 121168
Published online Oct 27, 2026. doi: 10.4240/wjgs.121168
Published online Oct 27, 2026. doi: 10.4240/wjgs.121168
Table 6 Safety analysis table, n (%)
| Type of adverse event | Grade 1 | Grade 2 | Grade 3 | Grade 4 | Overall incidence |
| Skin disorders | 18 (13.8) | 13 (10.0) | 3 (2.3) | 0 (0.0) | 34 (26.2) |
| Gastrointestinal disorders | 15 (11.5) | 9 (6.9) | 2 (1.5) | 0 (0.0) | 26 (20.0) |
| Endocrine disorders | 12 (9.2) | 8 (6.2) | 2 (1.5) | 0 (0.0) | 22 (16.9) |
| Respiratory disorders | 5 (3.8) | 3 (2.3) | 0 (0.0) | 1 (0.8) | 9 (6.9) |
| Hepatic function impairment | 4 (3.1) | 2 (1.5) | 0 (0.0) | 2 (1.5) | 8 (6.2) |
| Fatigue | 10 (7.7) | 5 (3.8) | 0 (0.0) | 0 (0.0) | 15 (11.5) |
| Other | 6 (4.6) | 3 (2.3) | 0 (0.0) | 0 (0.0) | 9 (6.9) |
| Total | 70 (53.8) | 50 (38.5) | 7 (5.4) | 3 (2.3) | 130 (100.0) |
- Citation: Zhang K, Li ZJ. Correlation between pathological response to neoadjuvant immunotherapy and long-term survival in locally advanced rectal cancer: A real-world study. World J Gastrointest Surg 2026; 18(10): 121168
- URL: https://www.wjgnet.com/1948-9366/full/v18/i10/121168.htm
- DOI: https://dx.doi.org/10.4240/wjgs.121168